Education
About Us
Working with TipRanks
Follow Us
Lexeo Therapeutics, Inc. (LXEO)
NASDAQ:LXEO
LXEO Analyst Ratings
Strong Buy
4 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
LXEO Stock 12 Month Forecast
Average Price Target
$20.50
▲(413.78% Upside)
| Highest Price Target$23.00 | Average Price Target$20.50 | Lowest Price Target$18.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
H.C. Wainwright
Reiterated
03/25/25
Leerink Partners
Reiterated
03/24/25
RBC Capital
Reiterated
03/24/25
Stifel Nicolaus
Reiterated
02/10/25
Robert W. Baird
$28
Buy
601.75%
Upside
Reiterated
11/20/24
Lexeo Therapeutics' Promising Gene Therapy Progress and Strong Financial Position Present Attractive Investment Opportunity
Chardan Capital
$23→$25
Buy
526.57%
Upside
Reiterated
11/13/24
Lexeo Therapeutics price target raised to $25 from $23 at ChardanLexeo Therapeutics price target raised to $25 from $23 at Chardan
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
Reiterated
03/25/25
Leerink Partners
Reiterated
03/24/25
RBC Capital
Reiterated
03/24/25
Stifel Nicolaus
Reiterated
02/10/25
Robert W. Baird
$28
Buy
601.75%
Upside
Reiterated
11/20/24
Lexeo Therapeutics' Promising Gene Therapy Progress and Strong Financial Position Present Attractive Investment Opportunity
Chardan Capital
$23→$25
Buy
526.57%
Upside
Reiterated
11/13/24
Lexeo Therapeutics price target raised to $25 from $23 at ChardanLexeo Therapeutics price target raised to $25 from $23 at Chardan
LXEO Analyst Recommendation Trends
Rating
Oct 24
Nov 24
Jan 25
Feb 25
Mar 25
Strong Buy
15
14
10
7
5
Buy
1
1
1
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
16
15
11
7
5
Each month's total comprises the sum of three months' worth of ratings.
LXEO Financial Forecast
LXEO Stock Forecast FAQ
What is LXEO’s average 12-month price target, according to analysts?
Based on analyst ratings, Lexeo Therapeutics, Inc.’s 12-month average price target is $20.50.
What is LXEO’s upside potential, based on the analysts’ average price target?
Lexeo Therapeutics, Inc. has 413.78% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is LXEO a Buy, Sell or Hold?
Lexeo Therapeutics, Inc. has a consensus rating of Strong Buy which is based on 4 buy ratings, 0 hold ratings and 0 sell ratings.
What is Lexeo Therapeutics, Inc.’s price target?
The average price target for Lexeo Therapeutics, Inc. is $20.50. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $23.00 ,the lowest forecast is $18.00. The average price target represents 413.78% Increase from the current price of $3.99.
The highest analyst price target is $23.00 ,the lowest forecast is $18.00. The average price target represents 413.78% Increase from the current price of $3.99.
What do analysts say about Lexeo Therapeutics, Inc.?
Lexeo Therapeutics, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
How can I buy shares of LXEO?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.